The present invention relates to a novel dicarboximide derivative of berbamine represented by formula I, including, but not limited to, a phthalimide derivative of berbamine and an aromatic heterocyclic dicarboximide derivative of berbamine, or a pharmaceutically acceptable salt thereof, to a process for preparation of the same, to a pharmaceutical composition comprising said compound and to use thereof in manufacture of an antitumor medicament.
本发明涉及一种由式 I 表示的新型
小檗胺二甲
酰亚胺衍
生物,包括但不限于
小檗胺的邻苯二甲
酰亚胺衍
生物和
小檗胺的芳香杂环二甲
酰亚胺衍
生物,或其药学上可接受的盐;本发明还涉及制备该衍
生物的工艺;本发明还涉及包含所述化合物的药物组合物,以及将其用于生产
抗肿瘤药物的用途。